Despite move to offer alternative brand after blood clot concern
Some people under the age of 30 are still being offered the Oxford-AstraZeneca vaccine despite a move by government to offer a different brand.
The health minister has blamed slower take up of the vaccine in the younger age group but says it's still in line with advice from the Joint Committee on Vaccination and Immunisation:
The decision to offer an alternative vaccination came after a scientific review found a potential link between Oxford-AstraZeneca and blood clots.
David Ashford says the guidance issued was due to an ‘abundance of caution’ and people are free to make their own choice:
Ard-Shirveishagh hopes he's given members enough time to consider 'Charter for Change'
Live video streaming 'significant step' in making parliament more accessible
Treasury: 'Challenging to justify support for heating oil customers'
Increase of more than 500 patients for mental health services over last 12 months
